Clinical Trial

Electroacupuncture Regulation of Immune Cells in Herpes Zoster

Recruiting
View on ClinicalTrials.gov →
Summary
Herpes Zoster (HZ), caused by the Varicella-Zoster Virus (VZV), is a common infection characterized by localized pain and blistering, with higher incidence in females. HZ affects patients' physical health, mental well-being, and quality of life. The immune system is critical in HZ pathogenesis. Studies show acupuncture relieves pain, modulates immunity, and may lower postherpetic neuralgia (PHN) risk. However, evidence is limited on whether electroacupuncture (EA) alleviates HZ by modulating immune cells. Using mass cytometry (CyTOF), this study will analyze peripheral immune cell changes pre- and post-EA to explore its regulatory effects on HZ immunity. This study will recruit HZ patients and healthy controls (HC), dividing patients into medication-only and medication+EA groups to assess EA's potential immunomodulatory effects in HZ treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-10-12; most recent amendment 2026-02-01.
Status change: Not Yet Recruiting → Recruiting 2024-11-16
Trial Details
NCT Number NCT06643247
Lead Sponsor First People's Hospital of Hangzhou
Conditions Herpes Zoster, Electroacupuncture, Immune
Enrollment 8 participants
Start Date 2024-11-11
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-03